Clinical trial
Prevalence and Predictors of Esophageal Thermal Lesions in High-Power-Short-Duration Ablation of Atrial Fibrillation
NCT05709756 is registered in ClinicalTrials.gov with Helios Health Institute GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence and Predictors of Esophageal Thermal Lesions in High-Power-Short-Duration Ablation of Atrial Fibrillation
- Lead sponsor
- Helios Health Institute GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- September 1, 2023
- Enrollment
- 263 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, esophagus injury